Death after High-Dose rAAV9 Gene Therapy in a Patient with Duchenne’s Muscular DystrophyAngela Lek, Terence R. Flotte, Katelyn Sylvia et al.|New England Journal of Medicine|2023Cited by 302
Pronounced Therapeutic Benefit of a Single Bidirectional AAV Vector Administered Systemically in Sandhoff MiceHannah G. Lahey, Miguel Sena‐Esteves, Chelsea Joy Webber et al.|Molecular Therapy|2020Cited by 36
Unexpected Death of a Duchenne Muscular Dystrophy Patient in an N-of-1 Trial of rAAV9-delivered CRISPR-transactivatorAngela Lek, Terence R. Flotte, Brenda Wong et al.|medRxiv|2023Cited by 34